Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Exercise Test × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 5 Prostatic Neoplasms 4 Lung Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Motor Activity 2 Lymphoma, Non-Hodgkin 2 Hodgkin Disease 2 Hematopoietic and Lymphoid System Neoplasm 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Sleep Wake Disorders 1 Pelvic Neoplasms 1 Pancreatic Neoplasms 1 Obesity 1 Neoplasm, Residual 1 Myelodysplastic Syndromes 1 Melanoma 1 Malignant Solid Neoplasm 1 Malignant Primary Pelvic Neoplasm 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Hairy Cell 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Hematopoietic and Lymphatic System Neoplasm 1 Heart Defects, Congenital 1 Fatigue 1 FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1

Interventions

pembrolizumab 49 Cisplatin 38 Radiotherapy 24 Cetuximab 22 Carboplatin 20 Nivolumab 15 Paclitaxel 14 Docetaxel 14 Surveys and Questionnaires 11 Fluorouracil 11 Drug Therapy 10 Blood Specimen Collection 10 Radiotherapy, Intensity-Modulated 8 tislelizumab 7 atezolizumab 6 Radiation 6 Standard of Care 5 Afatinib 5 cemiplimab 4 Chemoradiotherapy 4 toripalimab 3 palbociclib 3 dostarlimab 3 Surgical Procedures, Operative 3 Magnetic Resonance Spectroscopy 3 Immune Checkpoint Inhibitors 3 Fulvestrant 3 Erlotinib Hydrochloride 3 Equipment and Supplies 3 Capecitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡